Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7734310

Concept 2016-06-01 to
2017-05-31
As at
2017-05-31
As at
2017-05-31
2016-06-01 to
2017-05-31
2015-06-01 to
2016-05-31
As at
2016-05-31
As at
2016-05-31
2015-06-01 to
2016-05-31
2014-06-01 to
2015-05-31
2014-06-01 to
2015-05-31
As at
2015-05-31
As at
2015-05-31
2013-06-01 to
2014-05-31
2013-06-01 to
2014-05-31
As at
2014-05-31
As at
2014-05-31
As at
2013-05-31
2012-06-01 to
2013-05-31
2012-06-01 to
2013-05-31
As at
2013-05-31
Key financial data of reporting company
Business results of reporting company
Net sales
37,984,428,000 JPY
37,787,701,000 JPY
36,370,538,000 JPY
36,229,869,000 JPY
33,907,697,000 JPY
34,058,658,000 JPY
31,047,842,000 JPY
31,196,388,000 JPY
28,825,375,000 JPY
28,956,292,000 JPY
Ordinary profit (loss)
3,878,829,000 JPY
3,167,410,000 JPY
3,713,707,000 JPY
3,421,369,000 JPY
3,251,345,000 JPY
3,452,541,000 JPY
2,426,638,000 JPY
2,920,719,000 JPY
2,147,811,000 JPY
2,541,381,000 JPY
Profit (loss)
2,156,524,000 JPY
2,377,446,000 JPY
2,114,369,000 JPY
1,560,076,000 JPY
1,511,150,000 JPY
Share capital
4,367,774,000 JPY
4,367,774,000 JPY
4,367,774,000 JPY
3,120,301,000 JPY
3,120,301,000 JPY
Total number of issued shares
12,519,000 xbrli:shares
12,519,000 xbrli:shares
12,519,000 xbrli:shares
10,874,000 xbrli:shares
9,885,000 xbrli:shares
Net assets
23,259,950,000 JPY
25,813,882,000 JPY
21,656,179,000 JPY
23,560,308,000 JPY
19,851,963,000 JPY
21,854,620,000 JPY
14,983,930,000 JPY
16,624,630,000 JPY
13,744,563,000 JPY
15,073,717,000 JPY
Total assets
41,458,633,000 JPY
45,707,887,000 JPY
39,632,978,000 JPY
43,340,231,000 JPY
38,952,277,000 JPY
42,305,155,000 JPY
33,778,253,000 JPY
36,694,726,000 JPY
31,491,295,000 JPY
34,762,268,000 JPY
Net assets per share
1,858.69
2,027.00
1,730.50
1,850.47
1,586.22
1,714.75
1,377.95
1,496.91
1,390.36
1,492.10
Dividend paid per share
33.00
30.00
30.00
30.00
30.00
Interim dividend paid per share
15.00
15.00
15.00
Basic earnings (loss) per share
212.26
172.32
205.07
189.97
172.75
183.51
143.47
166.58
164.19
194.13
Diluted earnings per share
Equity-to-asset ratio
0.561 xbrli:pure
0.555 xbrli:pure
0.546 xbrli:pure
0.534 xbrli:pure
0.510 xbrli:pure
0.507 xbrli:pure
0.444 xbrli:pure
0.444 xbrli:pure
0.436 xbrli:pure
0.424 xbrli:pure
Rate of return on equity
0.105 xbrli:pure
0.093 xbrli:pure
0.111 xbrli:pure
0.110 xbrli:pure
0.107 xbrli:pure
0.105 xbrli:pure
0.104 xbrli:pure
0.111 xbrli:pure
0.110 xbrli:pure
0.121 xbrli:pure
Price-earnings ratio
10.56 xbrli:pure
13.00 xbrli:pure
13.19 xbrli:pure
14.24 xbrli:pure
15.23 xbrli:pure
14.34 xbrli:pure
10.81 xbrli:pure
9.31 xbrli:pure
8.11 xbrli:pure
6.86 xbrli:pure
Payout ratio
0.192 xbrli:pure
0.158 xbrli:pure
0.174 xbrli:pure
0.190 xbrli:pure
0.183 xbrli:pure
Net cash provided by (used in) operating activities
5,069,743,000 JPY
2,948,858,000 JPY
3,739,312,000 JPY
2,744,650,000 JPY
2,541,424,000 JPY
Net cash provided by (used in) investing activities
-3,011,827,000 JPY
-4,015,152,000 JPY
-4,594,504,000 JPY
-2,162,669,000 JPY
-2,236,993,000 JPY
Net cash provided by (used in) financing activities
-1,777,711,000 JPY
526,301,000 JPY
502,890,000 JPY
-2,065,447,000 JPY
1,690,456,000 JPY
Cash and cash equivalents
1,617,337,000 JPY
1,351,135,000 JPY
1,918,749,000 JPY
2,285,657,000 JPY
3,698,606,000 JPY
Number of employees
595 xbrli:pure
726 xbrli:pure
586 xbrli:pure
712 xbrli:pure
536 xbrli:pure
664 xbrli:pure
505 xbrli:pure
615 xbrli:pure
490 xbrli:pure
579 xbrli:pure
Average number of temporary employees
31 xbrli:pure
32 xbrli:pure
31 xbrli:pure
32 xbrli:pure
31 xbrli:pure
32 xbrli:pure
32 xbrli:pure
33 xbrli:pure
31 xbrli:pure
32 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.